Senior Pet Nutrition: What Older Dogs and Cats Need to Stay Healthy

Veterinary medicine has helped dogs and cats live longer, but pet nutrition hasn’t settled what those extra years require. More than a third of dogs and cats are now classified as senior. Dogs are often considered senior from about age seven, though size matters: giant breeds may reach that stage around 7.5 years, while some guidance places it later, at 10 or 11. Cats are generally considered senior from 10 or 11, with some guidelines reserving “geriatric” for the final quarter of life. The longest recorded lifespans exceed 31 years for dogs and 38 for cats.^1–4

Here’s the gap: commercial feeding standards were built around growth and adult maintenance, and there’s still no regulatory or scientific consensus defining a senior dog’s or cat’s nutrient requirements. A food labeled for seniors may therefore contain much the same nutrient levels as an adult maintenance diet. Without shared standards, manufacturers set their own ideas about what senior nutrition should mean.^2,3

Aging also changes the body in ways a standard maintenance diet may not address. Older pets can lose lean muscle even when their appetite and weight appear normal; in cats, that loss may begin in middle age and remain hidden as body weight holds steady. Dogs and cats also tend to conserve water less effectively and feel less thirst, while reduced kidney response to arginine vasopressin—also called antidiuretic hormone—can further raise dehydration risk. Omega-3 fatty acids may become more relevant as inflammatory needs shift, and age brings greater risk of joint disease, cognitive decline, and chronic kidney disease, particularly in cats.^2,3,5,6

That makes targeted supplementation a reasonable area to examine, but the evidence is uneven. Research has focused on cognition, mobility and joint health, kidney support, and muscle preservation. The strongest findings concern long-chain omega-3 fatty acids; many other products have narrower evidence, and studies often combine several ingredients. The discussion that follows weighs what peer-reviewed research says for dogs and cats, including where results don’t carry across species.

Cognition: promising ingredients, thin evidence

Cognitive decline is common in older pets, though reported rates depend on age and how researchers define the condition. Canine cognitive dysfunction affects an estimated 20–68 percent of senior dogs; roughly one-third of cats aged 11 to 14 show signs, with prevalence rising in older cats. Yet a 2025 systematic review found only 30 clinical trials of enriched diets or nutraceuticals: 27 in dogs and just two in cats.^3,7

Among the nutrients reviewed, EPA and DHA have the most consistent cognitive evidence in both species. At roughly 26–67.5 mg/kg DHA and 27–43 mg/kg EPA, higher intakes improved learning and cognition. In one year-long cat study, a diet enriched with EPA, DHA, vitamins E and C, B vitamins, and arginine improved learning, executive function, and visuospatial performance in middle-aged and older animals.^7,8

DHA is abundant in brain tissue, and several proposed mechanisms make its effects plausible: it may help maintain synaptic membrane fluidity, support phosphatidylserine production and brain signaling, reduce inflammatory metabolites, strengthen antioxidant defenses, promote neurogenesis, and increase glucose transporter activity.^3,7 Plausibility isn’t the same as proof for every pathway, but the clinical evidence for omega-3s is stronger than for most alternatives.

In dogs, diets containing about 5.5–9 percent medium-chain triglycerides improved executive and visuospatial performance in laboratory and household settings, likely by increasing ketones that aging neurons can use for fuel. Cat evidence is absent. SAMe may support executive function in both species by increasing brain glutathione and reducing oxidative stress, though the evidence remains limited.^3,7,9

Other positive findings come from small canine studies. Apoaequorin improved learning and executive function in a short trial; homotaurine improved learning and executive function and helped prevent memory decline over a year. Neither has been evaluated in cats. A placebo-controlled study in aged beagles also found better short-term memory with a combination of phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.^7,10

Antioxidants used alone—including plant polyphenols and vitamins E and C—have produced disappointing results in dogs. One possible explanation is an “antioxidant paradox”: at high doses, antioxidants may act as pro-oxidants. Pairing antioxidants with mitochondrial cofactors ALCAR and alpha-lipoic acid has shown more consistent memory benefits, but the doses matter. LA at 2.7 mg/kg and ALCAR at 27.5 mg/kg each tended to worsen learning; together, 2.7 mg/kg LA plus 5.4 mg/kg ALCAR improved memory in two of three trials. This combination hasn’t been studied in cats, where alpha-lipoic acid is more toxic.⁷

Arginine at 315–390 mg/kg, N-acetyl cysteine at 4–17 mg/kg, L-carnitine at 2.7–4.7 mg/kg, and B vitamins have shown positive effects when used in combinations. Tryptophan, by contrast, has not demonstrated a consistent benefit in dogs. Multi-ingredient formulas and small studies make it hard to pin results on any one nutrient; inconsistent cognitive tests add another complication. Long-term work is needed to establish both safety and efficacy in dogs and cats.⁷

Joints, inflammation, and muscle

EPA and DHA also have the broadest support for age-related joint problems. Their metabolites are less inflammatory than those derived from omega-6 fatty acids, and omega-3s may help limit muscle breakdown and support protein synthesis through mTOR signaling—potentially useful against sarcopenia, the loss of muscle with age.³

Canine dosing depends on the condition being treated. Published guidance reaches 310 mg × body weight (kg)^0.75 of combined EPA and DHA for orthopedic disease, compared with 140 mg × body weight (kg)^0.75 for kidney concerns and 115 mg × body weight (kg)^0.75 for cardiovascular indications. Feline guidance is less developed; suggested combined intake is 200–300 mg per cat per day. Because polyunsaturated fats oxidize readily, adding vitamin E or another antioxidant is recommended when supplementing with omega-3s.^3,11,12

A 2022 meta-analysis covering 72 trials and 38 nutraceuticals in dogs and cats with osteoarthritis found meaningful pain relief from omega-3-enriched diets and supplements—the strongest evidence among the categories reviewed. Placebo-controlled, multicenter dog trials reported improved weight bearing and reduced need for carprofen with fish oil, with a clear dose response. A high-omega-3 therapeutic diet produced comparable results in another canine trial. In cats, dietary long-chain omega-3s improved owner-reported behavior and movement in naturally occurring osteoarthritis, with similar findings for a high-omega-3 therapeutic diet.^11,13–19

Some combination products have encouraging but narrower results. A placebo-controlled crossover trial found that green-lipped mussel, curcumin, and blackcurrant leaf extract improved osteoarthritis scores and grooming behavior in cats, with a larger apparent effect in cats than dogs. A small 2026 study used accelerometers and machine learning to assess a multi-ingredient joint supplement in senior cats. The formula included green-lipped mussels, salmon oil, vitamin C, blackcurrant extract, curcumin, glucosamine, chondroitin, and vitamin D3. Cats didn’t show a consistent rise in total activity, though activity patterns became more stable and grooming increased. That result also shows how difficult it can be to measure feline joint health.^20,21

Glucosamine-chondroitin combinations have a long history in veterinary practice, but the same meta-analysis found essentially no benefit. Collagen products have only weak support; undenatured type II collagen (UC-II) and eggshell membrane showed slight positive results in limited trials. When a supplement contains several active ingredients, it’s difficult to identify which one produced the effect.^2,13

Muscle loss is the less studied side of aging, especially in cats. Their lean mass can decline while fat mass keeps weight stable or pushes it higher. Proposed contributors to feline sarcopenia and cachexia include loss of type II muscle fibers, mitochondrial dysfunction, reduced growth hormone and IGF-1 signaling, resistance to the muscle-building effects of protein, and low-grade inflammation. That resistance raises a practical question: senior cats may need more dietary protein, not less. Muscle loss also contributes to frailty and the risk of poor outcomes.⁵

No drug or nutritional supplement has been specifically researched or approved for sarcopenic cats. Leucine, creatine, and ursolic acid are candidates, but their promise remains preliminary. In dogs recovering from tibial plateau leveling osteotomy, a fertilized egg yolk-derived myostatin inhibitor helped preserve thigh circumference during activity restriction, while placebo-treated dogs lost muscle. That study addressed post-surgical disuse atrophy, not age-related muscle loss. For now, adequate high-quality, bioavailable protein has the strongest general support, and checking cats’ lean mass matters even when the scale shows no change.^3,5,22

Kidney health and phosphorus

Chronic kidney disease becomes more common with age in dogs and cats. Estimates put its prevalence as high as 80.9 percent in cats over 15, making kidney health one of the central concerns in feline senior nutrition.⁶ Excess highly bioavailable inorganic phosphorus—often added to cat foods and treats for palatability—has been linked to dose-dependent kidney injury and disease progression. Senior labeling doesn’t require a lower phosphorus level, so clinicians need to check each product’s guaranteed analysis. “All Life Stage” foods meet growth recommendations and contain higher mineral levels, including phosphorus, that senior pets don’t need.^3,23–25

For dogs with or at risk of kidney disease, combined EPA and DHA intake around 140 mg × body weight (kg)^0.75 may help. A 2025 double-blind, placebo-controlled trial tested a daily renal supplement alongside a therapeutic kidney diet in dogs with advanced disease. Its ingredients included chitosan, sodium bicarbonate, calcium carbonate, calcium lactate gluconate, Lactobacillus acidophilus D2/CSL, Olea europaea L. extract, and fructooligosaccharides. Compared with diet alone, the supplement group had lower proteinuria, blood urea nitrogen, and serum phosphorus, with creatinine and SDMA remaining stable. Because both groups received a renal diet, the supplement’s independent contribution is difficult to isolate.²⁶

No comparable supplement trial has been reported in cats. One study of 80 client-owned geriatric cats found that those eating a diet enriched with fish oil, L-carnitine, and medium-chain triglycerides maintained stable SDMA and creatinine over six months, while cats eating their owners’ chosen diets showed rising SDMA. Hydration matters in both species with kidney disease, especially as aging reduces thirst response.^2,3,27,28

What the evidence supports

The case for senior supplements is strongest when it’s specific to the animal and the condition. Long-chain omega-3s have the broadest support across cognition, joint health, and inflammation in dogs and cats. Other ingredients may help in particular settings, especially cognitive decline or kidney disease, but results often come from small trials or multi-ingredient formulas. Glucosamine-chondroitin has little meaningful evidence, and muscle-loss research—particularly in cats—remains sparse.

With no agreed nutrient requirements for senior pets, age on a package label can’t substitute for assessing body condition, kidney function, cognition, mobility, and muscle mass. Larger, standardized, placebo-controlled studies are needed, especially in cats, whose evidence base trails dogs across every area reviewed.^2,3,5,13

Laura B. Gaylord, DVM, DACVIM (Nutrition), is an independent consultant and founder of Whole Pet Provisions, PLLC, a nutrition consulting company established in 2016. The company advises pet owners, veterinarians, the pet food industry, and pet supplement companies. Dr. Gaylord also formulates homemade diets and consults on commercial diets for pet parents and their veterinary teams.

References

What the evidence can—and can’t—tell us

The research behind nutrition for aging pets spans several distinct problems: maintaining muscle and mobility, supporting cognition, and managing kidney disease. That breadth matters. It also makes sweeping claims about “senior” diets hard to defend: the studies listed here examine different species, conditions, ingredients, and outcomes.

For mobility, much of the cited work focuses on omega-3 fatty acids and other supplements in dogs with osteoarthritis, with additional studies on cats and therapeutic diets. Some research tracks outcomes such as weight bearing, medication needs, or owners’ perceptions of movement. Those measures can be useful, but they don’t all answer the same question. If you’re weighing a joint product, the ingredient list alone won’t tell you how strong the evidence is for that specific formulation.

Cognition is another active area. Studies have tested nutrient blends and supplements in older dogs and cats, while a later systematic review assessed enriched diets and nutraceuticals. The range of approaches is promising, but the citations themselves don’t establish that every supplement works, or that results for one blend apply to another. The same caution applies to muscle and frailty: research on muscle loss in older cats sits alongside a dog study of Fortetropin after surgery, which addresses a narrower setting.

Kidney health calls for close attention to the details

The kidney research raises a point that can get lost in broad advice about restricting phosphorus or protein. Studies have examined how different phosphorus sources affect blood concentrations in cats, how calcium-to-phosphorus ratios change those responses, and how nutritional interventions relate to kidney biomarkers in geriatric cats. Other work covers chronic kidney disease management and a supplement trial in dogs. These are related questions, but they aren’t interchangeable evidence for a single dietary rule.

That’s the larger takeaway: nutrition can be part of managing age-related disease, but the evidence is condition-specific and still developing. A 2024 call to revisit nutrient guidelines, alongside newer reviews and studies, suggests the field is still working out what older pets need and how best to measure benefit. The obvious read is that more products are being studied. The more useful read is that owners and clinicians need to look past “senior” labels and ask which outcome a diet or supplement was actually tested against.

References

1. Churchill, J.A.; Eirmann, L. Senior Pet Nutrition and Management. Clin. N. Am. Small Anim. Pract. 2021, 51, 635–651. https://doi.org/10.1016/j.cvsm.2021.01.004.
2. Cai, X., Mao, H., & Zhu, L. (2026). Nutrition research in aging dogs and cats: What we know and what we need to do. Animals, 16(4), 571. https://doi.org/10.3390/ani16040571
3. Stockman, J. (2024). Nutrition and aging in dogs and cats. In G. Wu (Ed.), Nutrition and metabolism of dogs and cats (Advances in Experimental Medicine and Biology, Vol. 1446, pp. 203–215). Springer. https://doi.org/10.1007/978-3-031-54192-6_9
4. Bermingham, E.N.; Patterson, K.A.; Shoveller, A.K.; Fraser, K.; Butowski, C.F.; Thomas, D.G. Nutritional needs and health outcomes of ageing cats and dogs: Is it time for updated nutrient guidelines? Anim. Front. 2024, 14, 5–16.
5. Chandler, M. (2026). Sarcopenia, cachexia and frailty in older cats: Mechanisms, assessment and therapeutic considerations. Journal of Feline Medicine and Surgery, 28(7). https://doi.org/10.1177/1098612X261426765
6. Marino, C. L., Lascelles, B. D. X., Vaden, S. L., Gruen, M. E., & Marks, S. L. (2014). Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. Journal of Feline Medicine and Surgery, 16(6), 465–472.
7. Blanchard, T., Eppe, J., Mugnier, A., Delfour, F., & Meynadier, A. (2025). Enhancing cognitive functions in aged dogs and cats: A systematic review of enriched diets and nutraceuticals. GeroScience, 47, 2925–2947. https://doi.org/10.1007/s11357-025-01521-z
8. Pan, Y., Araujo, J. A., Burrows, J., de Rivera, C., Gore, A., Bhatnagar, S., et al. (2013). Cognitive enhancement in middle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine. British Journal of Nutrition, 110(1), 40–49.
9. Araujo, J. A., Faubert, M. L., Brooks, M. L., & Lobprise, H. (2012). NOVIFIT® (NoviSAMe®) tablets improve executive function in aged dogs and cats: Implications for treatment of cognitive dysfunction syndrome. International Journal of Applied Research in Veterinary Medicine, 10(2), 90–98.
10. Araujo JA, Landsberg GM, Milgram NW, Miolo A. "Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine." The Canadian Veterinary Journal. 2008;49(4):379-385. PMID: 18481547; free full text: PMC2275342.
11. Lascelles, B., DePuy, V., Thomson, A., et al. (2010). Evaluation of a therapeutic diet for feline degenerative joint disease. Journal of Veterinary Internal Medicine, 24(3), 487–495.
12. Parker, V. J. (2021). Nutritional management for dogs and cats with chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice, 51(3), 685–710.
13. Barbeau-Grégoire, M., Otis, C., Cournoyer, A., Moreau, M., Lussier, B., & Troncy, E. (2022). A 2022 systematic review and meta-analysis of enriched therapeutic diets and nutraceuticals in canine and feline osteoarthritis. International Journal of Molecular Sciences, 23(18), 10384. https://doi.org/10.3390/ijms231810384
14. Fritsch, D. A., Allen, T. A., Dodd, C. E., Jewell, D. E., Sixby, K. A., Leventhal, P. S., Brejda, J., & Hahn, K. A. (2010a). A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(5), 535–539. https://doi.org/10.2460/javma.236.5.535
15. Roush, J. K., Dodd, C. E., Fritsch, D. A., Allen, T. A., Jewell, D. E., Schoenherr, W. D., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010a). Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Journal of the American Veterinary Medical Association, 236(1), 59–66.
16. Roush, J. K., Cross, A. R., Renberg, W. C., Dodd, C. E., Sixby, K. A., Fritsch, D. A., Allen, T. A., Jewell, D. E., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010b). Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(1), 67–73.
17. Fritsch, D. A., Allen, T. A., Dodd, C. E., Jewell, D. E., Sixby, K. A., Leventhal, P. S., & Hahn, K. A. (2010b). Dose-titration effects of fish oil in osteoarthritic dogs. Journal of Veterinary Internal Medicine, 24(5), 1020–1026. https://doi.org/10.1111/j.1939-1676.2010.0572.x
18. Moreau, M., Troncy, E., Del Castillo, J. R. E., Bédard, C., Gauvin, D., & Lussier, B. (2013). Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition, 97(5), 830–837. https://doi.org/10.1111/j.1439-0396.2012.01325.x
19. Corbee, R. J. (2013). The effect of dietary long-chain omega-3 fatty acid supplementation on owner's perception of behaviour and locomotion in cats with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition, 97. https://doi.org/10.1111/j.1439-0396.2012.01329.x
20. Corbee, R. J. (2022). The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. Veterinary Medicine and Science, 8(3), 1025–1035. https://doi.org/10.1002/vms3.779
21. Liu, Y., Smit, M., Andrews, C. J., Corner-Thomas, R. A., Draganova, I., & Thomas, D. G. (2026). Evaluating the efficacy of a joint supplement in senior cats using accelerometry and machine learning. Pets, 3(3), 40. https://doi.org/10.3390/pets3030040
22. White, D. A., Harkin, K. R., Roush, J. K., Renberg, W. C., & Biller, D. (2020). Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy. PLOS ONE, 15(4), e0231306. https://doi.org/10.1371/journal.pone.0231306
23. Coltherd, J. C., Staunton, R., Colyer, A., Thomas, G., Gilham, M., Logan, D. W., Butterwick, R., & Watson, P. (2019). Not all forms of dietary phosphorus are equal: An evaluation of postprandial phosphorus concentrations in the plasma of the cat. British Journal of Nutrition, 121(3), 270–284.
24. Coltherd, J. C., Alexander, J. E., Pink, C., et al. (2021). Towards establishing no observed adverse effect levels (NOAEL) for different sources of dietary phosphorus in feline adult diets: Results from a 7-month feeding trial. British Journal of Nutrition, 126(11), 1626–1641.
25. Coltherd, J. C., Staunton, R., Colyer, A., et al. (2022). Dietary calcium to phosphorus ratio affects postprandial phosphorus concentrations in feline plasma. British Journal of Nutrition, 128(9), 1689–1699.
26. Perondi, F., Ruggiero, A., Cutrignelli, M. I., Lippi, I., Meineri, G., & Martello, E. (2025). Efficacy of a once-daily supplement in managing canine chronic kidney disease. Animals, 15(19), 2884. https://doi.org/10.3390/ani15192884
27. Hall, J. A., Yerramilli, M., Obare, E., Yerramilli, M., Yu, S., & Jewell, D. E. (2014). Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in healthy geriatric cats fed reduced protein foods enriched with fish oil, L-carnitine, and medium-chain triglycerides. The Veterinary Journal, 202(3), 588–596.
28. Hall, J. A., MacLeay, J., Yerramilli, M., Obare, E., Yerramilli, M., Schiefelbein, H., Paetau-Robinson, I., & Jewell, D. E. (2016). Positive impact of nutritional interventions on serum symmetric dimethylarginine and creatinine concentrations in client-owned geriatric cats. PLOS ONE, 11(4), e0153654.